MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update

Go back to MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update
(NASDAQ: INKT) Delayed: 11.82 --0 (-0%)
Previous Close $11.82    52 Week High
Open $11.82    52 Week Low
Day High $11.82    P/E N/A 
Day Low $11.82    EPS
Volume